Crimean-Congo hemorrhagic fever is an emerging infectious disease in Turkey, with nearly 10,000 cases since 2002.
Early supportive treatment is essential for the management of CCHF.
Research is needed to investigate and develop antiviral drugs, immune therapy and vaccines.
There is a need for rapid diagnostic methods with high sensitivity and specificity.
A robust surveillance system, education and community engagement are keys to finding cases early and improving outcomes.